page_banner

Media

As the first manufacturer in Beijing to obtain the third-class certificate of medical devices for the COVID-19 nucleic acid detection reagent, Beijing Applied Biological Technologies Co., Ltd. (referred to as ‘XABT’) was once again reported by CCTV.

img (5)

(CCTV-2) In anticipation of the surge in demand for nucleic acid testing after the holiday, many nucleic acid testing kit manufacturers did not close during the Spring Festival. At the same time, due to the rising demand in overseas markets, many companies are working overtime to expand their production scale.

img (3)
img (1)

In the production workshop for nucleic acid detection and dispensing solutions, the staff told reporters that the demand for nucleic acid detection surged during the Spring Festival. Hospitals, disease control, and third-party testing institutions have increased their stockpiles, and orders for nucleic acid testing kits have also increased rapidly in various places.

img (4)

Beijing Applied Biological Technologies Co., Ltd. Vice president JiangFan

From the beginning of the outbreak of the COVID-19 to the present, XABT has rapidly increased the production capacity of test kits through a series of measures such as investment in automation equipment and optimization of technological processes, ensuring the supply of the company's testing products and services, and helping various places to fight the epidemic. In addition, this self-test product of XABT is mainly sent to Europe, the Middle East, and Southeast Asian countries. At present, in response to the high incidence of the global epidemic, we continue to expand our production capacity to ensure supply in overseas markets.

At present, the global epidemic is still spreading, and the virus is constantly mutating, posing new challenges to global public health. XABT continues to pay attention to the changes in the global epidemic, closely tracks the latest developments of the global SARS-CoV-2 variant, monitors the specificity, accuracy and sensitivity of the products, and continues to support the prevention and control of the COVID-19.

Complete Solution for the COVID-19 Diagnosis

XABT research and develop over 400 kinds of pathogenic microorganism detection products, including Respiratory Tract Infection, Food-Borne and Digestive Tract Infection, Fever and A Rash, Emerging and Re-Emerging Infectious Disease Detection and other series, covering sample collection to amplification analysis of the systematic solution for hospitals, disease prevention, and control centers, food and drug supervision system, entry-exit inspection and quarantine system, etc.

01 Real-Time PCR Kit for Detection of 6 Respiratory Viruses

img (2)

On April 14, 2021, the National Health Commission of China and the National Administration of Traditional Chinese Medicine jointly issued the ‘COVID-19 Diagnosis and Treatment Protocol (Eighth Edition, Revised)’, pointing out that COVID-19 should be distinguished from other known viral pneumonia such as influenza virus, adenovirus and respiratory syncytial virus, etc. The Multiple Real-time PCR Kit for Detection of 6 Respiratory Viruses (PCR Fluorescent Probe Method) developed and marketed by XABT [NMPA: 20213400026] can well meet the needs. The reagent based on multiple PCR technology to detect Influenza A virus, Influenza B virus, respiratory syncytial virus, adenovirus, parainfluenza I virus and parainfluenza III virus at the same time, facilitating accurate clinical diagnosis.  

img (3)

02 Multiple Real-Time PCR Kit for Detection of 2019-nCoV

Multiple Real-Time PCR Kit for Detection of 2019-nCoV (PCR Fluorescent Probe Method) [NMPA: 20203400179], which can detect whether the virus is contained in the human body at the early stage, thus providing direct evidence of virus infection. The kit is used for in vitro qualitative detection of COVID-19 suspected cases and clustered cases, by targeting SARS-CoV-2 virus ORF1ab gene, N gene and E gene in sputum and oropharyngeal swab samples.

03 Real-Time PCR Kit for Detection of 2019-nCoV Mutations

While making all-out efforts to ensure the supply of COVID-19 detection reagents, XABT also closely tracked the mutation dynamics of COVID-19, and promptly developed more than a dozen of Real-time PCR Kit for Detection of COVID-19 Mutations, including the Omicron mutant strain, to identify mutant strains and conduct epidemiological monitoring of new outbreaks.  

img (1)
img (2)

04 SARS-CoV-2 Antigen Rapid Test Cassette

XABT provides a rapid antigen tests for detecting the presence of COVID-19 virus, it is a faster and less expensive way to diagnose active SARS-CoV-2 infection than nucleic acid amplification tests.


Post time: Mar-01-2022